TrialAntimicrobial agents and chemotherapy2006

Phase II, randomized, double-blind, multicenter study comparing the safety and pharmacokinetics of tefibazumab to placebo for treatment of Staphylococcus aureus bacteremia.

J John Weems et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.